Hasan “Lucas” Seyhun, the chief operating officer of Fast Lab Technologies, pleaded guilty September 23 to conspiracy to commit health care fraud in a nationwide scheme that logged more than $500 million in fake COVID-19 test claims, according to the U.S. Attorney’s Office for the Eastern District of Michigan. Seyhun, 45, of Miami, personally received at least $35 million from the scheme, prosecutors said, while a separate forfeiture money judgment against him totals $4,313,153. Two co-defendants, Fast Lab’s CEO and medical director, face related charges in the same case.
A guilty plea, not a resolved account: The plea closes a criminal case over $500 million in fake claims, but anyone whose insurance information was used for a no-cost test still needs a paper trail, which The Senior Fraud Defense & First-Hour Recovery Kit’s evidence and report log is built for. Start a fraud evidence and report log →
How the fake-billing scheme worked
According to prosecutors, Fast Lab Technologies advertised “no cost” COVID-19 tests that customers ordered online, then used the insurance information those customers provided to submit claims for services that were never actually performed. The company billed government-backed health programs for antigen tests it falsely claimed medical professionals had observed, for saliva samples it falsely claimed medical personnel had collected, and for PCR testing it falsely claimed had been run on those samples.
Prosecutors went further, alleging that Fast Lab and its executives “routinely submitted claims for payment before test kits were even delivered to the customer,” meaning the billing did not wait for any interaction with the person whose insurance information was on file, real or fabricated. Over time those claims accumulated into the more than $500 million in fake billing at the center of the case…